Healthcare provider profile · identity verified

Michael D D'Amico, MD

Family Practice · FRANKLIN, WI · NPI 1386722866

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	605	161
Amlodipine Besylate	Amlodipine Besylate	379	98
Lisinopril	Lisinopril	288	84
Losartan Potassium	Losartan Potassium	232	59
Metoprolol Succinate	Metoprolol Succinate	230	67
Levothyroxine Sodium	Levothyroxine Sodium	220	55
Simvastatin	Simvastatin	216	61
Pantoprazole Sodium	Pantoprazole Sodium	178	49
Rosuvastatin Calcium	Rosuvastatin Calcium	176	56
Gabapentin	Gabapentin	166	53
Metformin Hcl Er	Metformin Hcl	147	41
Metformin Hcl	Metformin Hcl	142	39
Omeprazole	Omeprazole	138	43
Allopurinol	Allopurinol	135	34
Albuterol Sulfate Hfa	Albuterol Sulfate	121	45
Sertraline Hcl	Sertraline Hcl	116	29
Fluticasone Propionate	Fluticasone Propionate	113	38
Metoprolol Tartrate	Metoprolol Tartrate	110	32
Hydrochlorothiazide	Hydrochlorothiazide	108	33
Tamsulosin Hcl	Tamsulosin Hcl	106	33
Glipizide	Glipizide	99	29
Trazodone Hcl	Trazodone Hcl	97	27
Furosemide	Furosemide	92	30
Tramadol Hcl	Tramadol Hcl	92	20
Clopidogrel	Clopidogrel Bisulfate	75	20
Atenolol	Atenolol	73	19
Eliquis	Apixaban	73	17
Zolpidem Tartrate	Zolpidem Tartrate	73	12
Alendronate Sodium	Alendronate Sodium	72	24
Famotidine	Famotidine	71	19
Escitalopram Oxalate	Escitalopram Oxalate	64	19
Duloxetine Hcl	Duloxetine Hcl	61	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	16
Alprazolam	Alprazolam	52	16
Xarelto	Rivaroxaban	50	16
Potassium Chloride	Potassium Chloride	49	17
Carvedilol	Carvedilol	47	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	11
Januvia	Sitagliptin Phosphate	43	suppressed
Bupropion Xl	Bupropion Hcl	42	suppressed
Lorazepam	Lorazepam	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	13
Pravastatin Sodium	Pravastatin Sodium	42	15
Warfarin Sodium	Warfarin Sodium	41	suppressed
Celecoxib	Celecoxib	40	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	12
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	38	11
Montelukast Sodium	Montelukast Sodium	38	12
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	12
Diazepam	Diazepam	34	suppressed
Clonazepam	Clonazepam	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Jardiance	Empagliflozin	31	suppressed
Nitroglycerin	Nitroglycerin	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	21
Meloxicam	Meloxicam	29	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	12
Amoxicillin	Amoxicillin	27	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Baclofen	Baclofen	22	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	22	suppressed
Metronidazole	Metronidazole	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Indapamide	Indapamide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Rivastigmine	Rivastigmine Tartrate	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Azithromycin	Azithromycin	13	13
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Adderall Xr	Dextroamphetamine/Amphetamine	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Colchicine	Colchicine	11	suppressed
Estradiol	Estradiol	11	suppressed
Finasteride	Finasteride	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Metolazone	Metolazone	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error